PMID: 9634492Jun 20, 1998Paper

Modification of tumor blood flow: current status and future directions

Seminars in Radiation Oncology
D J ChaplinGillian M Tozer

Abstract

Suboptimal drug distribution and hypoxia, which can contribute to treatment failure, are a direct consequence of the spatial and temporal heterogeneity in perfusion that occurs in solid tumors. Therefore, improvements in tumor blood flow have wide-ranging therapeutic importance. Paradoxically, controlled decreases in tumor blood flow can also be exploited and, if permanent, induce extensive tumor cell death on their own. We review the current knowledge of the factors controlling tumor blood flow with emphasis on the roles of the endogeneous vasodilator nitric oxide and the endogenous vasoconstrictor endothelin-1. The potential importance and application of approaches that irreversibly damage vascular function, so-called vascular targeting, are also discussed. Emphasis is given to the drug-based approaches to vascular targeting that are now entering clinical evaluation. There is no doubt that increased understanding of the processes that determine blood flow in tumors, coupled with the availability of techniques to monitor blood flow noninvasively in the clinic, will enable strategies for selectively modifying tumor blood flow to be transferred from the laboratory to the clinical setting.

References

Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E A CarswellB Williamson
Dec 1, 1992·British Journal of Pharmacology·S P AndradeP J Piper
Jun 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A RojasJ Denekamp
Jul 1, 1991·International Journal of Radiation Biology·H I Peterson
Jul 1, 1991·International Journal of Radiation Biology·D J Chaplin
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·M R HorsmanJ Overgaard
Nov 1, 1991·Japanese Journal of Cancer Research : Gann·K HoriQ H Zhang
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M J TrotterP L Olive
Oct 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·E KjellenA Rojas
Apr 18, 1990·Journal of the National Cancer Institute·D J ChaplinM J Trotter
Feb 1, 1990·The Journal of Clinical Investigation·C Boulanger, T F Lüscher
Aug 1, 1990·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·N P RowellA Horwich
Oct 1, 1985·The British Journal of Dermatology·H TakematsuT Kato
Jan 1, 1989·Journal of Cardiovascular Pharmacology·T D WarnerJ R Vane
Apr 19, 1989·Journal of the National Cancer Institute·D J Chaplin
May 1, 1989·International Journal of Radiation Oncology, Biology, Physics·D J ChaplinP L Olive
Jul 5, 1989·Journal of the National Cancer Institute·L J ZwiW R Wilson
Feb 1, 1989·Journal of the National Cancer Institute·M C BibbyC V Duke
Mar 1, 1989·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·M R HorsmanJ Overgaard
Aug 1, 1988·British Journal of Cancer·I J StratfordN Timpson
Aug 1, 1988·European Journal of Cancer & Clinical Oncology·M A BurtonA Coletti
Jul 1, 1988·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·R L Jirtle
Apr 1, 1987·International Journal of Radiation Oncology, Biology, Physics·D J Chaplin, B Acker
Jun 1, 1970·British Journal of Cancer·G CalcuttA V Preece
Mar 1, 1974·Radiology·L Ekelund, A Lunderquist
Oct 1, 1982·European Journal of Cancer & Clinical Oncology·W D Voorhees, C F Babbs
Jun 15, 1994·International Journal of Radiation Oncology, Biology, Physics·P J WoodJ R Vane
Feb 1, 1995·Trends in Pharmacological Sciences·T P FanR Bicknell
Jul 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S Y Chou, J G Porush
Sep 27, 1995·International Journal of Cancer. Journal International Du Cancer·S A HillD J Chaplin
Jan 1, 1995·Lasers in Surgery and Medicine·A M FisherC J Gomer
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·F J Burrows, P E Thorpe

❮ Previous
Next ❯

Citations

Oct 26, 2005·Breast Cancer Research and Treatment·N V RajeshkumarAnil Gulati
Jan 20, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H WildiersA T van Oosterom
Jun 15, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J BussinkA J van der Kogel
Mar 4, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M KocherR P Müller
Aug 5, 2000·International Journal of Radiation Oncology, Biology, Physics·A P van den BergA G Visser
Sep 7, 2000·International Journal of Radiation Oncology, Biology, Physics·B F JordanB Gallez
Feb 28, 2003·International Journal of Radiation Oncology, Biology, Physics·Bénédicte F JordanBernard Gallez
Oct 8, 2003·International Journal of Radiation Oncology, Biology, Physics·I Frank CiernikGustav K Von Schulthess
Dec 9, 1998·International Journal of Radiation Oncology, Biology, Physics·D K KelleherP Vaupel
Sep 7, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R D BlumenthalD M Goldenberg
Dec 11, 2002·The Lancet Oncology·Johannes H A M KaandersAlbert J van der Kogel
Aug 6, 2004·International Journal of Hematology·Gavin Thurston, Nicholas W Gale
Feb 6, 2007·International Journal of Radiation Oncology, Biology, Physics·Pierre SonveauxOlivier Feron
Jan 17, 2015·Colloids and Surfaces. B, Biointerfaces·Marilene EstanqueiroJosé Manuel Sousa Lobo
Jun 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Helen L AndersonPatricia M Price
Feb 14, 2006·The Journal of Biological Chemistry·Goutam ChakrabortyGopal C Kundu
May 18, 2010·Expert Review of Anticancer Therapy·Tomaz JarmGregor Sersa
Oct 25, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Pierre SonveauxOlivier Feron
Apr 19, 2003·Physics in Medicine and Biology·Thomas G A Purdie, Ting-Yim Lee
Nov 16, 2017·Drug Development and Industrial Pharmacy·Pham Van QuyetPaul Wan Sia Heng
Apr 24, 2003·Experimental Biology and Medicine·Amel F KhelifiGillian M Tozer
Nov 8, 2017·Current Eye Research·Matthias BrunnerStephen B Kaye
Mar 15, 2003·Physiological Measurement·Tomaz JarmDamijan Miklavcic
Sep 3, 2004·Cancer Research·Kevin L Bennewith, Ralph E Durand
Dec 12, 2001·Current Problems in Cancer·M M PoggiJ B Mitchell
May 12, 2004·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Marjeta SentjurcGregor Sersa
Apr 4, 2020·Anti-cancer Agents in Medicinal Chemistry·Ahmed El-HusseinPatience Mthunzi-Kufa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
R D BlumenthalD M Goldenberg
The British Journal of Radiology
S DischeB D Michael
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Donna Young
© 2022 Meta ULC. All rights reserved